

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66106119 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.66106119 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27065487 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.27065487 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.85472611 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.20296602 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.20296602 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.20296602 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.06471655 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.89354469 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.87275537 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.85144342 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52400980 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51075719 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.47048967 |
| 16 | urea cycle (GO:0000050) | 5.41512136 |
| 17 | urea metabolic process (GO:0019627) | 5.41512136 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.41011220 |
| 19 | cysteine metabolic process (GO:0006534) | 5.34261370 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.32630430 |
| 21 | protein carboxylation (GO:0018214) | 5.26529194 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.26529194 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.24378060 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.15298313 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.03678297 |
| 26 | bile acid metabolic process (GO:0008206) | 5.03549842 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.00211939 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.98940064 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.96741117 |
| 30 | regulation of complement activation (GO:0030449) | 4.79017765 |
| 31 | tyrosine metabolic process (GO:0006570) | 4.78437306 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.77320521 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.73960090 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.72591009 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.71449437 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.65756900 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.62322203 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.62322203 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.62322203 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.61907009 |
| 41 | coenzyme catabolic process (GO:0009109) | 4.56334635 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.52537152 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.52537152 |
| 44 | amine catabolic process (GO:0009310) | 4.46256458 |
| 45 | cellular biogenic amine catabolic process (GO:0042402) | 4.46256458 |
| 46 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.39731584 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 4.39602579 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.34629023 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.33624226 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.33624226 |
| 51 | phospholipid efflux (GO:0033700) | 4.31799908 |
| 52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.26950551 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.26516581 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.26169767 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.23909292 |
| 56 | positive regulation of protein kinase C signaling (GO:0090037) | 4.23042872 |
| 57 | lysine catabolic process (GO:0006554) | 4.21681228 |
| 58 | lysine metabolic process (GO:0006553) | 4.21681228 |
| 59 | glycine metabolic process (GO:0006544) | 4.20566405 |
| 60 | glutamate metabolic process (GO:0006536) | 4.19390450 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.17119795 |
| 62 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 4.16662019 |
| 63 | cellular glucuronidation (GO:0052695) | 4.14778069 |
| 64 | cholesterol efflux (GO:0033344) | 4.12768601 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.12470465 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.07792052 |
| 67 | exogenous drug catabolic process (GO:0042738) | 4.07029893 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.03488515 |
| 69 | epoxygenase P450 pathway (GO:0019373) | 4.03096755 |
| 70 | arginine metabolic process (GO:0006525) | 4.02559225 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 4.02140313 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 4.00960053 |
| 73 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.00290674 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.97674597 |
| 75 | ethanol oxidation (GO:0006069) | 3.97380322 |
| 76 | aldehyde catabolic process (GO:0046185) | 3.94483776 |
| 77 | cofactor catabolic process (GO:0051187) | 3.89853205 |
| 78 | fibrinolysis (GO:0042730) | 3.87573406 |
| 79 | regulation of plasminogen activation (GO:0010755) | 3.87380322 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81376948 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.81015882 |
| 82 | drug catabolic process (GO:0042737) | 3.80885433 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77877588 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.76822254 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75274638 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75274638 |
| 87 | intestinal cholesterol absorption (GO:0030299) | 3.73639460 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72922331 |
| 89 | organic acid catabolic process (GO:0016054) | 3.70288849 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.70288849 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70170199 |
| 92 | short-chain fatty acid metabolic process (GO:0046459) | 3.70117731 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.68322822 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.68322822 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.66699335 |
| 96 | opsonization (GO:0008228) | 3.61911598 |
| 97 | sterol homeostasis (GO:0055092) | 3.61549148 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.61454282 |
| 99 | NAD biosynthetic process (GO:0009435) | 3.60809073 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60366108 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.59961256 |
| 102 | diacylglycerol metabolic process (GO:0046339) | 3.59115157 |
| 103 | complement activation, classical pathway (GO:0006958) | 3.56968980 |
| 104 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55603954 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55603954 |
| 106 | negative regulation of protein activation cascade (GO:2000258) | 3.54854415 |
| 107 | protein activation cascade (GO:0072376) | 3.54355023 |
| 108 | complement activation (GO:0006956) | 3.52183038 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.51989739 |
| 110 | ketone body metabolic process (GO:1902224) | 3.49346480 |
| 111 | regulation of triglyceride metabolic process (GO:0090207) | 3.48027337 |
| 112 | semaphorin-plexin signaling pathway (GO:0071526) | 3.42334790 |
| 113 | positive regulation of fatty acid oxidation (GO:0046321) | 3.37747332 |
| 114 | acute-phase response (GO:0006953) | 3.35299169 |
| 115 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34859624 |
| 116 | drug metabolic process (GO:0017144) | 3.29876179 |
| 117 | alkaloid metabolic process (GO:0009820) | 3.21079682 |
| 118 | regulation of cholesterol metabolic process (GO:0090181) | 3.19550113 |
| 119 | negative regulation of cell size (GO:0045792) | 3.16119206 |
| 120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.15008735 |
| 121 | intestinal absorption (GO:0050892) | 3.10693519 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.09158353 |
| 123 | proline metabolic process (GO:0006560) | 3.08733113 |
| 124 | regulation of apoptotic cell clearance (GO:2000425) | 2.99200565 |
| 125 | ethanol metabolic process (GO:0006067) | 2.98230120 |
| 126 | phenylpropanoid metabolic process (GO:0009698) | 2.97795495 |
| 127 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.97304313 |
| 128 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.96121737 |
| 129 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.96121737 |
| 130 | negative regulation of hemostasis (GO:1900047) | 2.94430917 |
| 131 | negative regulation of blood coagulation (GO:0030195) | 2.94430917 |
| 132 | omega-hydroxylase P450 pathway (GO:0097267) | 2.94270810 |
| 133 | sulfate transmembrane transport (GO:1902358) | 2.92681931 |
| 134 | quaternary ammonium group transport (GO:0015697) | 2.89025482 |
| 135 | lung epithelium development (GO:0060428) | 2.89019754 |
| 136 | oxidative demethylation (GO:0070989) | 2.86787622 |
| 137 | regulation of ruffle assembly (GO:1900027) | 2.82726980 |
| 138 | plasma lipoprotein particle organization (GO:0071827) | 2.81418609 |
| 139 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.81113751 |
| 140 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.81033387 |
| 141 | mannose metabolic process (GO:0006013) | 2.79867064 |
| 142 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.78795640 |
| 143 | positive regulation of histone deacetylation (GO:0031065) | 2.75902537 |
| 144 | nephron tubule morphogenesis (GO:0072078) | 2.75636545 |
| 145 | nephron epithelium morphogenesis (GO:0072088) | 2.75636545 |
| 146 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.74227898 |
| 147 | acute inflammatory response (GO:0002526) | 2.71529064 |
| 148 | chondroitin sulfate catabolic process (GO:0030207) | 2.68181106 |
| 149 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.67307786 |
| 150 | negative regulation of coagulation (GO:0050819) | 2.66346675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.97892158 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83481228 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.74404556 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.25075152 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14548974 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90243227 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.14300270 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.92604004 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.76799958 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.91201866 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.76025447 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.50842975 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.42562170 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29944581 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.23821151 |
| 16 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.14580037 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.13975649 |
| 18 | P68_20966046_ChIP-Seq_HELA_Human | 2.13411768 |
| 19 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.00709091 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3111557 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96428091 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89454467 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89272380 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84320417 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79447302 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71856957 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.71371171 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71303165 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66910873 |
| 30 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.65474748 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.64864135 |
| 32 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64314574 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63788281 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.62790666 |
| 35 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.59964802 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55916372 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55543838 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55113842 |
| 39 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52530613 |
| 40 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.51486702 |
| 41 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.50657031 |
| 42 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.49894803 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.49479681 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47106931 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43031979 |
| 46 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42539712 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42447105 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42408395 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41581959 |
| 50 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38797345 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38149498 |
| 52 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36025482 |
| 53 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.33524185 |
| 54 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.33183767 |
| 55 | SA1_27219007_Chip-Seq_Bcells_Human | 1.33015702 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30826536 |
| 57 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.27640715 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23005819 |
| 59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22634538 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21815666 |
| 61 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21487077 |
| 62 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21263694 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20622668 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17659773 |
| 65 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16754983 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16254086 |
| 67 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15428009 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15086212 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12473655 |
| 70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10396188 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09410370 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08992730 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 1.06834221 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05842663 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04364395 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04092884 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03611160 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02666462 |
| 79 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02557094 |
| 80 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.02324113 |
| 81 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02222652 |
| 82 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.00128736 |
| 83 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99979950 |
| 84 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.99640952 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98881547 |
| 86 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98775799 |
| 87 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98014748 |
| 88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97789257 |
| 89 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96855850 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96754756 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96690447 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96690447 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95085492 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94947298 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94504900 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94388763 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92791035 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92473690 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92171689 |
| 100 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91577054 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91344497 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88875201 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85447727 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82584880 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80319911 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76636942 |
| 107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76432469 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75103646 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73368260 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73049033 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69583588 |
| 112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68968032 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66935934 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66380825 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66190638 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65761851 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65179044 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.62531353 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61829733 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.61641931 |
| 121 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61385179 |
| 122 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60736829 |
| 123 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59306948 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59011687 |
| 125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.58924703 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56643349 |
| 127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.56561332 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.56485712 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55513258 |
| 130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.54775705 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54680779 |
| 132 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.54647731 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.53647082 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53516551 |
| 135 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.53346369 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.53223471 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53199706 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53162742 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.52971897 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50155799 |
| 141 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.50122392 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48040481 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.47670274 |
| 144 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.47380872 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46919763 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46482811 |
| 147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.46273368 |
| 148 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.45746360 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.45457980 |
| 150 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.45319597 |
| 151 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.44815186 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44567168 |
| 153 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.44317412 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44017097 |
| 155 | NCOR_22424771_ChIP-Seq_293T_Human | 0.43944511 |
| 156 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.43688696 |
| 157 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.43677196 |
| 158 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43072711 |
| 159 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.41491095 |
| 160 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.41263398 |
| 161 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41099863 |
| 162 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40439139 |
| 163 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.40380933 |
| 164 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40069005 |
| 165 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.39624167 |
| 166 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.38792778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.08167626 |
| 2 | MP0005360_urolithiasis | 7.25045523 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.40149786 |
| 4 | MP0005365_abnormal_bile_salt | 6.12764637 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03916499 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19967635 |
| 7 | MP0003252_abnormal_bile_duct | 3.91866481 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49247330 |
| 9 | MP0005083_abnormal_biliary_tract | 3.29903987 |
| 10 | MP0002249_abnormal_larynx_morphology | 3.17083940 |
| 11 | MP0003195_calcinosis | 2.95481589 |
| 12 | MP0009840_abnormal_foam_cell | 2.91016325 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.87924271 |
| 14 | MP0000678_abnormal_parathyroid_gland | 2.85321231 |
| 15 | MP0005332_abnormal_amino_acid | 2.80023829 |
| 16 | MP0003879_abnormal_hair_cell | 2.58553322 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.58045780 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.22323488 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.22313988 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.18996832 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.18328991 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.11848247 |
| 23 | MP0000609_abnormal_liver_physiology | 2.08514062 |
| 24 | MP0003868_abnormal_feces_composition | 1.96104490 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.83005736 |
| 26 | MP0001849_ear_inflammation | 1.82539979 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.78852891 |
| 28 | MP0009697_abnormal_copulation | 1.68980355 |
| 29 | MP0001764_abnormal_homeostasis | 1.68847569 |
| 30 | MP0001502_abnormal_circadian_rhythm | 1.64630237 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.62272457 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.58039304 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52629109 |
| 34 | MP0005451_abnormal_body_composition | 1.48793684 |
| 35 | MP0002933_joint_inflammation | 1.43826584 |
| 36 | MP0003186_abnormal_redox_activity | 1.40046707 |
| 37 | MP0003011_delayed_dark_adaptation | 1.37915607 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.33929499 |
| 39 | MP0005409_darkened_coat_color | 1.32544738 |
| 40 | MP0005647_abnormal_sex_gland | 1.24836856 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.24366997 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.23507009 |
| 43 | MP0002932_abnormal_joint_morphology | 1.22314801 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.20954246 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.15764430 |
| 46 | MP0000767_abnormal_smooth_muscle | 1.15131370 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.12786099 |
| 48 | MP0000598_abnormal_liver_morphology | 1.11805154 |
| 49 | MP0009764_decreased_sensitivity_to | 1.09303748 |
| 50 | MP0004858_abnormal_nervous_system | 1.09269653 |
| 51 | MP0003283_abnormal_digestive_organ | 1.08944659 |
| 52 | MP0000467_abnormal_esophagus_morphology | 1.04240081 |
| 53 | MP0001664_abnormal_digestion | 1.03950290 |
| 54 | MP0005408_hypopigmentation | 1.03544451 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.01800664 |
| 56 | MP0000604_amyloidosis | 1.01043269 |
| 57 | MP0000681_abnormal_thyroid_gland | 1.00460885 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.99716285 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 0.99446818 |
| 60 | MP0006292_abnormal_olfactory_placode | 0.98477645 |
| 61 | MP0009763_increased_sensitivity_to | 0.97833843 |
| 62 | MP0010368_abnormal_lymphatic_system | 0.96537895 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.94548824 |
| 64 | MP0001873_stomach_inflammation | 0.94247636 |
| 65 | MP0001958_emphysema | 0.93827963 |
| 66 | MP0002254_reproductive_system_inflammat | 0.93078616 |
| 67 | MP0005375_adipose_tissue_phenotype | 0.91890893 |
| 68 | MP0005646_abnormal_pituitary_gland | 0.89317177 |
| 69 | MP0005503_abnormal_tendon_morphology | 0.85966019 |
| 70 | MP0003938_abnormal_ear_development | 0.85800214 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.85183725 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.83798687 |
| 73 | MP0008469_abnormal_protein_level | 0.83213976 |
| 74 | MP0002234_abnormal_pharynx_morphology | 0.82265733 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.80890193 |
| 76 | MP0006138_congestive_heart_failure | 0.80245183 |
| 77 | MP0003690_abnormal_glial_cell | 0.79230144 |
| 78 | MP0003045_fibrosis | 0.77169136 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.76587264 |
| 80 | MP0003137_abnormal_impulse_conducting | 0.75810352 |
| 81 | MP0005670_abnormal_white_adipose | 0.75455731 |
| 82 | MP0004133_heterotaxia | 0.74514116 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.72243011 |
| 84 | MP0002822_catalepsy | 0.71332512 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.71262979 |
| 86 | MP0000538_abnormal_urinary_bladder | 0.70307570 |
| 87 | MP0004381_abnormal_hair_follicle | 0.69651228 |
| 88 | MP0000026_abnormal_inner_ear | 0.68838610 |
| 89 | MP0005334_abnormal_fat_pad | 0.68584197 |
| 90 | MP0003718_maternal_effect | 0.68515807 |
| 91 | MP0001756_abnormal_urination | 0.67671209 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.67309488 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.67001796 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.66645436 |
| 95 | MP0002282_abnormal_trachea_morphology | 0.66173426 |
| 96 | MP0001881_abnormal_mammary_gland | 0.65712115 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.65393625 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.65287261 |
| 99 | MP0000163_abnormal_cartilage_morphology | 0.64837402 |
| 100 | MP0000537_abnormal_urethra_morphology | 0.64813411 |
| 101 | MP0003329_amyloid_beta_deposits | 0.64807297 |
| 102 | MP0009053_abnormal_anal_canal | 0.64621708 |
| 103 | MP0001661_extended_life_span | 0.63437962 |
| 104 | MP0005377_hearing/vestibular/ear_phenot | 0.62710311 |
| 105 | MP0003878_abnormal_ear_physiology | 0.62710311 |
| 106 | MP0005023_abnormal_wound_healing | 0.62451847 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.61304543 |
| 108 | MP0001501_abnormal_sleep_pattern | 0.59203457 |
| 109 | MP0003119_abnormal_digestive_system | 0.58910940 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.58886934 |
| 111 | MP0005395_other_phenotype | 0.58440839 |
| 112 | MP0002970_abnormal_white_adipose | 0.58183707 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.58127250 |
| 114 | MP0002971_abnormal_brown_adipose | 0.57378913 |
| 115 | MP0005535_abnormal_body_temperature | 0.56975913 |
| 116 | MP0004264_abnormal_extraembryonic_tissu | 0.56739480 |
| 117 | MP0003279_aneurysm | 0.56632778 |
| 118 | MP0008260_abnormal_autophagy | 0.55705221 |
| 119 | MP0000751_myopathy | 0.54679963 |
| 120 | MP0000371_diluted_coat_color | 0.53982481 |
| 121 | MP0003942_abnormal_urinary_system | 0.53806532 |
| 122 | MP0002928_abnormal_bile_duct | 0.50468076 |
| 123 | MP0005266_abnormal_metabolism | 0.49903998 |
| 124 | MP0000579_abnormal_nail_morphology | 0.49188861 |
| 125 | MP0003724_increased_susceptibility_to | 0.48795053 |
| 126 | MP0005448_abnormal_energy_balance | 0.48791729 |
| 127 | MP0000566_synostosis | 0.48297783 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.47278169 |
| 129 | MP0003075_altered_response_to | 0.46770743 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.45684513 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.45424359 |
| 132 | MP0004130_abnormal_muscle_cell | 0.43282678 |
| 133 | MP0008873_increased_physiological_sensi | 0.40881534 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.39227492 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.37632670 |
| 136 | MP0005166_decreased_susceptibility_to | 0.37417721 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.37390666 |
| 138 | MP0002796_impaired_skin_barrier | 0.37059697 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.36869118 |
| 140 | MP0004043_abnormal_pH_regulation | 0.36752156 |
| 141 | MP0008874_decreased_physiological_sensi | 0.36626843 |
| 142 | MP0003953_abnormal_hormone_level | 0.36623505 |
| 143 | MP0005164_abnormal_response_to | 0.36565512 |
| 144 | MP0010234_abnormal_vibrissa_follicle | 0.35363401 |
| 145 | MP0002060_abnormal_skin_morphology | 0.34926969 |
| 146 | MP0001243_abnormal_dermal_layer | 0.34823507 |
| 147 | MP0002168_other_aberrant_phenotype | 0.33310475 |
| 148 | MP0000249_abnormal_blood_vessel | 0.31808743 |
| 149 | MP0008872_abnormal_physiological_respon | 0.31255182 |
| 150 | MP0002132_abnormal_respiratory_system | 0.30959781 |
| 151 | MP0004883_abnormal_blood_vessel | 0.30532954 |
| 152 | MP0003453_abnormal_keratinocyte_physiol | 0.30198779 |
| 153 | MP0000427_abnormal_hair_cycle | 0.29883483 |
| 154 | MP0009672_abnormal_birth_weight | 0.28662988 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.27367813 |
| 156 | MP0002090_abnormal_vision | 0.25881534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46509079 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.30464603 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.30221319 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.64201455 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63846702 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.23445512 |
| 7 | Xanthomatosis (HP:0000991) | 6.14048318 |
| 8 | J-shaped sella turcica (HP:0002680) | 5.65901743 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.60293403 |
| 10 | Complement deficiency (HP:0004431) | 5.03394900 |
| 11 | Joint hemorrhage (HP:0005261) | 4.75531872 |
| 12 | Obstructive sleep apnea (HP:0002870) | 4.75290557 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.60538252 |
| 14 | Hyperglycinemia (HP:0002154) | 4.53789480 |
| 15 | Epidermoid cyst (HP:0200040) | 4.50103074 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.49202462 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49110308 |
| 18 | Hyperammonemia (HP:0001987) | 4.45864301 |
| 19 | Broad face (HP:0000283) | 4.38379555 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.37938002 |
| 21 | Fat malabsorption (HP:0002630) | 4.31142644 |
| 22 | Cervical subluxation (HP:0003308) | 4.31004326 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26167700 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21896837 |
| 25 | Stridor (HP:0010307) | 4.16401279 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15396323 |
| 27 | Lymphangioma (HP:0100764) | 4.11227406 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 4.00956997 |
| 29 | Ketosis (HP:0001946) | 3.99828366 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.98406626 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.98406626 |
| 32 | Hyperglycinuria (HP:0003108) | 3.94965580 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.84525560 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.83361276 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79617569 |
| 36 | Aortic regurgitation (HP:0001659) | 3.64516901 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.60757530 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.60387167 |
| 39 | Abnormality of complement system (HP:0005339) | 3.59853518 |
| 40 | Cerebral palsy (HP:0100021) | 3.57090347 |
| 41 | Steatorrhea (HP:0002570) | 3.40873633 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36589972 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.20842283 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18478573 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 3.13473131 |
| 46 | Spontaneous abortion (HP:0005268) | 3.09116630 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07474926 |
| 48 | Biconcave vertebral bodies (HP:0004586) | 3.05300400 |
| 49 | Myocardial infarction (HP:0001658) | 2.98807994 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.98454316 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.98454316 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.97552244 |
| 53 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.91013439 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.90792116 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.90792116 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.90792116 |
| 57 | Hepatocellular carcinoma (HP:0001402) | 2.90600918 |
| 58 | Vascular calcification (HP:0004934) | 2.80266090 |
| 59 | Joint stiffness (HP:0001387) | 2.80064955 |
| 60 | Bronchomalacia (HP:0002780) | 2.76614691 |
| 61 | Thin bony cortex (HP:0002753) | 2.72829839 |
| 62 | Neoplasm of the heart (HP:0100544) | 2.72340566 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.71403604 |
| 64 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.71352795 |
| 65 | Metabolic acidosis (HP:0001942) | 2.71299728 |
| 66 | Deformed sella turcica (HP:0002681) | 2.70160124 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.70136474 |
| 68 | Ketoacidosis (HP:0001993) | 2.69611427 |
| 69 | Lethargy (HP:0001254) | 2.64613053 |
| 70 | Flared iliac wings (HP:0002869) | 2.64010825 |
| 71 | Skin nodule (HP:0200036) | 2.61322532 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.53990409 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.52484432 |
| 74 | Gout (HP:0001997) | 2.52473723 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.52145584 |
| 76 | Nephritis (HP:0000123) | 2.51549864 |
| 77 | Neurodegeneration (HP:0002180) | 2.48858257 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.48726589 |
| 79 | Acanthocytosis (HP:0001927) | 2.42512582 |
| 80 | Nuclear cataract (HP:0100018) | 2.40992198 |
| 81 | Cerebral edema (HP:0002181) | 2.40844546 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.40518119 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40518119 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 2.38482584 |
| 85 | Enlarged kidneys (HP:0000105) | 2.37196752 |
| 86 | Malnutrition (HP:0004395) | 2.36731470 |
| 87 | Esophageal varix (HP:0002040) | 2.35619519 |
| 88 | Rectal prolapse (HP:0002035) | 2.34400545 |
| 89 | Ependymoma (HP:0002888) | 2.34201079 |
| 90 | Cholecystitis (HP:0001082) | 2.34102310 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.34102310 |
| 92 | Amyloidosis (HP:0011034) | 2.33028418 |
| 93 | Opisthotonus (HP:0002179) | 2.31472493 |
| 94 | Visceral angiomatosis (HP:0100761) | 2.28489218 |
| 95 | Vitreoretinal degeneration (HP:0000655) | 2.26754501 |
| 96 | Mitral stenosis (HP:0001718) | 2.26259150 |
| 97 | Cholelithiasis (HP:0001081) | 2.26035943 |
| 98 | Gingival bleeding (HP:0000225) | 2.25693761 |
| 99 | Irritability (HP:0000737) | 2.25608873 |
| 100 | Spastic diplegia (HP:0001264) | 2.25326655 |
| 101 | Brushfield spots (HP:0001088) | 2.25302790 |
| 102 | Glomerulonephritis (HP:0000099) | 2.25036689 |
| 103 | Cerebral aneurysm (HP:0004944) | 2.24069507 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 2.22072088 |
| 105 | Menorrhagia (HP:0000132) | 2.21633390 |
| 106 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.21138938 |
| 107 | Rickets (HP:0002748) | 2.19534863 |
| 108 | Pancreatitis (HP:0001733) | 2.19251065 |
| 109 | Hamartoma of the eye (HP:0010568) | 2.18167130 |
| 110 | Hypoplasia of the odontoid process (HP:0003311) | 2.14179418 |
| 111 | Sleep apnea (HP:0010535) | 2.13223833 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09512170 |
| 113 | Neonatal onset (HP:0003623) | 2.09142514 |
| 114 | Decreased circulating renin level (HP:0003351) | 2.04642850 |
| 115 | Vomiting (HP:0002013) | 2.02868917 |
| 116 | Hydroxyprolinuria (HP:0003080) | 2.01997369 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 2.01997369 |
| 118 | Abnormality of lateral ventricle (HP:0030047) | 2.01347502 |
| 119 | Prolonged QT interval (HP:0001657) | 2.01020846 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00749771 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.99883707 |
| 122 | Spinal canal stenosis (HP:0003416) | 1.99440468 |
| 123 | Hemangiomatosis (HP:0007461) | 1.99255151 |
| 124 | Renal cortical cysts (HP:0000803) | 1.98932284 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 1.96871218 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94478225 |
| 127 | Severe Myopia (HP:0011003) | 1.93894850 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.92430454 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 1.92237738 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91488810 |
| 131 | Thrombophlebitis (HP:0004418) | 1.89929699 |
| 132 | Genetic anticipation (HP:0003743) | 1.88707469 |
| 133 | Flat acetabular roof (HP:0003180) | 1.85169161 |
| 134 | Broad metatarsal (HP:0001783) | 1.84823563 |
| 135 | Aortic valve stenosis (HP:0001650) | 1.83826161 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.82792581 |
| 137 | Alkalosis (HP:0001948) | 1.82752684 |
| 138 | Hypophosphatemia (HP:0002148) | 1.82149592 |
| 139 | Aneurysm (HP:0002617) | 1.81589877 |
| 140 | Abnormality of vitamin metabolism (HP:0100508) | 1.81125669 |
| 141 | Poikilocytosis (HP:0004447) | 1.80714826 |
| 142 | Elevated hepatic transaminases (HP:0002910) | 1.79404152 |
| 143 | Abnormality of the sella turcica (HP:0002679) | 1.79236251 |
| 144 | Elevated alkaline phosphatase (HP:0003155) | 1.76288891 |
| 145 | Abnormality of the femoral head (HP:0003368) | 1.75896127 |
| 146 | Bradycardia (HP:0001662) | 1.74911269 |
| 147 | Confusion (HP:0001289) | 1.74715147 |
| 148 | Abnormality of the odontoid process (HP:0003310) | 1.73342442 |
| 149 | Pigmentary retinal degeneration (HP:0001146) | 1.73288800 |
| 150 | Nonimmune hydrops fetalis (HP:0001790) | 1.73056529 |
| 151 | Shallow orbits (HP:0000586) | 1.72749736 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.71693935 |
| 153 | Glycosuria (HP:0003076) | 1.71693935 |
| 154 | Abnormal atrioventricular conduction (HP:0005150) | 1.71591888 |
| 155 | Status epilepticus (HP:0002133) | 1.71389799 |
| 156 | Abnormality of the 1st metacarpal (HP:0010009) | 1.71158167 |
| 157 | Hypertriglyceridemia (HP:0002155) | 1.70706976 |
| 158 | Generalized hypopigmentation of hair (HP:0011358) | 1.70264195 |
| 159 | Atelectasis (HP:0100750) | 1.69633026 |
| 160 | Protuberant abdomen (HP:0001538) | 1.69443579 |
| 161 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.65785985 |
| 162 | Short 1st metacarpal (HP:0010034) | 1.65785985 |
| 163 | Focal segmental glomerulosclerosis (HP:0000097) | 1.65465394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.03348467 |
| 2 | SIK1 | 4.68208832 |
| 3 | FGFR4 | 3.88564934 |
| 4 | ERN1 | 3.48166260 |
| 5 | TAOK3 | 3.39304177 |
| 6 | INSRR | 3.15014374 |
| 7 | TNK2 | 3.11125182 |
| 8 | FRK | 2.58655025 |
| 9 | ERBB4 | 2.48578486 |
| 10 | WNK4 | 2.46229264 |
| 11 | NME1 | 2.44151975 |
| 12 | NTRK3 | 2.42094224 |
| 13 | PRKD2 | 2.24778601 |
| 14 | PIK3CG | 2.16872231 |
| 15 | AKT3 | 2.00785539 |
| 16 | MAP2K4 | 1.90246853 |
| 17 | DAPK2 | 1.89815924 |
| 18 | MST1R | 1.85538244 |
| 19 | STK38L | 1.77737274 |
| 20 | FGFR2 | 1.75950308 |
| 21 | LATS1 | 1.70336814 |
| 22 | PKN2 | 1.67476377 |
| 23 | IRAK3 | 1.62853218 |
| 24 | PTK6 | 1.61571645 |
| 25 | KDR | 1.58396559 |
| 26 | ICK | 1.56638262 |
| 27 | MARK2 | 1.54526651 |
| 28 | EPHB1 | 1.49888299 |
| 29 | PINK1 | 1.40218013 |
| 30 | NEK9 | 1.39829011 |
| 31 | RPS6KA2 | 1.38178789 |
| 32 | ABL2 | 1.37828053 |
| 33 | MAPK11 | 1.36114911 |
| 34 | LMTK2 | 1.35856453 |
| 35 | SIK2 | 1.31040204 |
| 36 | TYK2 | 1.26947942 |
| 37 | FLT3 | 1.25382103 |
| 38 | MAPK15 | 1.24122821 |
| 39 | MAP3K14 | 1.22626401 |
| 40 | MET | 1.21330823 |
| 41 | PRKCI | 1.19749600 |
| 42 | EEF2K | 1.16307131 |
| 43 | CDC42BPA | 1.16283295 |
| 44 | SMG1 | 1.12263741 |
| 45 | CAMK2G | 1.06016009 |
| 46 | PRKAA2 | 1.04716583 |
| 47 | GRK1 | 1.02918206 |
| 48 | RPS6KA6 | 1.01498464 |
| 49 | PRKG2 | 0.97974754 |
| 50 | TIE1 | 0.97748334 |
| 51 | MAP3K6 | 0.96877097 |
| 52 | HIPK2 | 0.96448676 |
| 53 | JAK2 | 0.96427046 |
| 54 | RPS6KL1 | 0.96322113 |
| 55 | RPS6KC1 | 0.96322113 |
| 56 | ERBB2 | 0.95590265 |
| 57 | PIK3CA | 0.93217222 |
| 58 | MAP3K7 | 0.91905765 |
| 59 | CAMKK1 | 0.87619791 |
| 60 | MAPKAPK3 | 0.86804473 |
| 61 | PRKCZ | 0.85765588 |
| 62 | TRIB3 | 0.85002885 |
| 63 | CHUK | 0.81562182 |
| 64 | PTK2 | 0.79402790 |
| 65 | DDR2 | 0.79041830 |
| 66 | EPHA4 | 0.78955474 |
| 67 | PBK | 0.78715076 |
| 68 | MAPK7 | 0.78569664 |
| 69 | ADRBK2 | 0.77129379 |
| 70 | EPHA2 | 0.75392836 |
| 71 | TBK1 | 0.75259836 |
| 72 | TLK1 | 0.74774566 |
| 73 | MATK | 0.74355746 |
| 74 | MTOR | 0.73287807 |
| 75 | JAK1 | 0.72747580 |
| 76 | MUSK | 0.69134471 |
| 77 | MAPK4 | 0.68449372 |
| 78 | STK38 | 0.68311631 |
| 79 | SGK223 | 0.67872434 |
| 80 | SGK494 | 0.67872434 |
| 81 | MAP4K1 | 0.66323930 |
| 82 | PKN1 | 0.65926697 |
| 83 | CAMK1 | 0.65673147 |
| 84 | TESK1 | 0.65337087 |
| 85 | STK39 | 0.65132672 |
| 86 | PDGFRA | 0.64939900 |
| 87 | CAMK1D | 0.62664682 |
| 88 | EPHB2 | 0.61974526 |
| 89 | PRKCQ | 0.61527260 |
| 90 | MAP2K2 | 0.60353941 |
| 91 | MAP2K7 | 0.60252522 |
| 92 | IRAK2 | 0.59910805 |
| 93 | MAP2K1 | 0.58088553 |
| 94 | MAP3K3 | 0.56851013 |
| 95 | GRK6 | 0.56768755 |
| 96 | PRKACG | 0.56126376 |
| 97 | MAPK12 | 0.56107669 |
| 98 | GSK3A | 0.55950884 |
| 99 | MAPK8 | 0.54070000 |
| 100 | PRKD3 | 0.53349511 |
| 101 | NUAK1 | 0.53122077 |
| 102 | ZAP70 | 0.52772739 |
| 103 | PDGFRB | 0.51901691 |
| 104 | PRKD1 | 0.51480601 |
| 105 | CSK | 0.51470740 |
| 106 | TGFBR2 | 0.50598388 |
| 107 | FGFR3 | 0.49581777 |
| 108 | ROCK1 | 0.49098129 |
| 109 | PDPK1 | 0.48297373 |
| 110 | MYLK | 0.47255942 |
| 111 | STK3 | 0.45427716 |
| 112 | SGK3 | 0.44993653 |
| 113 | CDK6 | 0.44874837 |
| 114 | IKBKB | 0.44760735 |
| 115 | RIPK1 | 0.43307221 |
| 116 | PAK3 | 0.43230287 |
| 117 | SGK2 | 0.42928342 |
| 118 | FER | 0.42162932 |
| 119 | IGF1R | 0.41360753 |
| 120 | DMPK | 0.40947970 |
| 121 | IRAK1 | 0.39345359 |
| 122 | CSNK1A1L | 0.38890198 |
| 123 | TAOK2 | 0.38180270 |
| 124 | PRKAA1 | 0.37786879 |
| 125 | PHKG1 | 0.37668399 |
| 126 | PHKG2 | 0.37668399 |
| 127 | MAPK3 | 0.37599971 |
| 128 | PDK1 | 0.37253749 |
| 129 | MAP2K6 | 0.36242764 |
| 130 | PRKCG | 0.36114008 |
| 131 | MAP3K11 | 0.36044511 |
| 132 | CSNK1G1 | 0.36041111 |
| 133 | DYRK1B | 0.35417521 |
| 134 | CAMK2B | 0.35093828 |
| 135 | IKBKE | 0.34423098 |
| 136 | MAPK1 | 0.34027524 |
| 137 | MAP2K3 | 0.33755246 |
| 138 | PLK4 | 0.32592083 |
| 139 | ABL1 | 0.32577547 |
| 140 | CSNK1A1 | 0.31711417 |
| 141 | MAPKAPK2 | 0.31696721 |
| 142 | OXSR1 | 0.31277903 |
| 143 | BMX | 0.30637565 |
| 144 | PRKCA | 0.28982375 |
| 145 | SRC | 0.28969266 |
| 146 | PRKCH | 0.28886947 |
| 147 | TAOK1 | 0.27846631 |
| 148 | CAMK1G | 0.26905064 |
| 149 | EPHA3 | 0.26864745 |
| 150 | MAP3K13 | 0.26182322 |
| 151 | CAMK4 | 0.25435736 |
| 152 | PTK2B | 0.22703658 |
| 153 | CSNK1G2 | 0.21833897 |
| 154 | MAP3K4 | 0.20538259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47336493 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48148385 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27068720 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19339365 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05314407 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.82618143 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72530503 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63686830 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60865516 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55541495 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37822674 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35795657 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19000408 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17757751 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.16368378 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.12915219 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07923150 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01209652 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99639344 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99093123 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96474330 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90344400 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89634468 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77234097 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75266480 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74549165 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72864166 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71877648 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69079776 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68964282 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67163932 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64578517 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59176690 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55626928 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51342509 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49935030 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48967935 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46605042 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.43657124 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42285149 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38461637 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31651838 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29136168 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27208851 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26493782 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24043583 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22912639 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.18393280 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16136984 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10502046 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08946624 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04831902 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 1.03982514 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03635217 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03337913 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99346574 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97142018 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96818226 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90259581 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82701400 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82350620 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77365558 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.73999972 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72812037 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70699831 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65781035 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65680468 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64869651 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61048101 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57055676 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56194135 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54008945 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50107261 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49653400 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45624194 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43886071 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43191699 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42621239 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40717689 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37945142 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34477604 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33606652 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31591329 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31149861 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31044414 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27982252 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.27667334 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27481173 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25984178 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.25644812 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25365457 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25208565 |
| 93 | Axon guidance_Homo sapiens_hsa04360 | 0.25046722 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23370445 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22840793 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.19842128 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19706932 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.19632812 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18843431 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18152904 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.16285289 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15667156 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.14233989 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14021296 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00445189 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.2309663 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | -0.2202234 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2109665 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2060930 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | -0.2033899 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1857200 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1833974 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1772312 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1761742 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1741169 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1619543 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | -0.1318526 |
| 118 | Protein export_Homo sapiens_hsa03060 | -0.1229059 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0969936 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0895742 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0580984 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0456889 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0451305 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0333414 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0328024 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0288006 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0112828 |

